Demonstrates biointerface modulation through alkyl chain length in supramolecular assemblies, suggesting novel applications.
Alkyl chain length is typically viewed as a passive modulator of lipophilicity in drug-like molecules. Here, we demonstrate that it instead functions as a molecular switch that reprograms supramolecular organization,...
No takes yet. Share an insight, caveat, or question.
Kholany et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: